Evidence map›Paper›PMID 27843150›Full record

ArticleMolecular psychiatry2017

The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior.

T Arentsen, Y Qian, S Gkotzis, T Femenia, T Wang, K Udekwu, H Forssberg, R Diaz Heijtz

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 285 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. The gut as a central hub for multi-organ crosstalk in aging.Cellular and molecular life sciences : CMLS · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Gut: The gate and key to brain.Chinese medical journal · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  16. Review
  17. Review
  18. Microbiome: A Key Regulator of Body-Brain Interactions.Advances in experimental medicine and biology · 2025
    Review
  19. Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

T ArentsenDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Y QianDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
S GkotzisDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
T FemeniaDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
T WangDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
K UdekwuDepartment of Molecular Biosciences, Stockholm University, Stockholm, Sweden.
H ForssbergDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
R Diaz HeijtzDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SEStockholm University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have revealed that the gut microbiota modulates brain development and behavior, but the underlying mechanisms are still poorly understood. Here, we show that bacterial peptidoglycan (PGN) derived from the commensal gut microbiota can be translocated into the brain and sensed by specific pattern-recognition receptors (PRRs) of the innate immune system. Using expression-profiling techniques, we demonstrate that two families of PRRs that specifically detect PGN (that is, PGN-recognition proteins and NOD-like receptors), and the PGN transporter PepT1 are highly expressed in the developing brain during specific windows of postnatal development in both males and females. Moreover, we show that the expression of several PGN-sensing molecules and PepT1 in the developing striatum is sensitive to manipulations of the gut microbiota (that is, germ-free conditions and antibiotic treatment). Finally, we used the PGN-recognition protein 2 (Pglyrp2) knockout mice to examine the potential influence of PGN-sensing molecules on brain development and behavior. We demonstrate that the absence of Pglyrp2 leads to alterations in the expression of the autism risk gene c-Met, and sex-dependent changes in social behavior, similar to mice with manipulated microbiota. These findings suggest that the central activation of PRRs by microbial products could be one of the signaling pathways mediating the communication between the gut microbiota and the developing brain.

Indexed as

AnimalsBrainCarrier ProteinsFemaleGastrointestinal MicrobiomeImmunity, InnateMaleMiceMice, KnockoutN-Acetylmuramoyl-L-alanine AmidasePeptidoglycanSignal TransductionCarrier ProteinsN-Acetylmuramoyl-L-alanine AmidasePeptidoglycanpeptidoglycan recognition proteinPglyrp2 protein, mouse

Identifiers

PMID27843150
PMCPMC5285465
OpenAlexW2551810737

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.